Affordable Access

The FDA should not adopt the nicotine “harm reduction” paradigm because doing so is likely to increase the amount of smoking-caused disease and death

Authors
  • Apollonio, Dorothy
  • Glantz, Stanton
  • Hall, Sharon
  • Lempert, Lauren
  • St Helen, Gideon
  • Tsoh, Janice
Publication Date
Nov 13, 2019
Source
eScholarship - University of California
License
Unknown
External links
Report this publication

Statistics

Seen <100 times